Thiamethoxam

CAS No. 153719-23-4

Thiamethoxam( (E)-thiamethoxam | Actara 25WG | Adage 5FS )

Catalog No. M26843 CAS No. 153719-23-4

Thiamethoxam is an insecticide of broad-spectrum neonicotinoids.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG 53 In Stock
500MG 87 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Thiamethoxam
  • Note
    Research use only, not for human use.
  • Brief Description
    Thiamethoxam is an insecticide of broad-spectrum neonicotinoids.
  • Description
    Thiamethoxam is an insecticide of broad-spectrum neonicotinoids.(In Vitro):Among the different treatments, The mean half-life of thiamethoxam was 3.7?days in the water column with concentrations of <0.8?μg/L in the majority of mesocosms .(In Vivo):Thiamethoxam does harm honey bee visual learning and increases abnormal behaviors .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (E)-thiamethoxam | Actara 25WG | Adage 5FS
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    hJNK1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    153719-23-4
  • Formula Weight
    291.71
  • Molecular Formula
    C8H10ClN5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN1COCN(Cc2cnc(Cl)s2)\C1=N\[N+]([O-])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kolb M, et, al. Therapeutic targets in idiopathic pulmonary fibrosis. Respir Med. 2017 Oct;131:49-57.
molnova catalog
related products
  • Schisantherin B

    Schisantherin B shows good effect in lowering the serum glutamic-pyruvic transaminase level of the patients suffering from chronic virus hepatitis.

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • N-(4-Fluorophenyl)-4...

    N-(4-Fluorophenyl)-4-phenyl-2-thiazolami is a potent, brain-penetrant and orally active GP130 receptor agonist.